Abstract
A higher incidence of cognitive impairment (CI) has previously been reported among orchiectomized testicular cancer patients (TCPs), but little is known about the underlying pathophysiology. The present study assessed CI in newly orchiectomized TCPs and explored the structural brain networks, endocrine status, and selected genotypes. Forty TCPs and 22 healthy controls (HCs) underwent neuropsychological testing and magnetic resonance imaging, and provided a blood sample. CI was defined as a z-score ≤ -2 on one neuropsychological test or ≤ -1.5 on two neuropsychological tests, and structural brain networks were investigated using graph theory. Associations of cognitive performance with brain networks, endocrine status (including testosterone levels and androgen receptor CAG repeat length), and genotypes (APOE, BDNF, COMT) were explored. Compared with HCs, TCPs performed poorer on 6 out of 15 neuropsychological tests, of which three tests remained statistically significant when adjusted for relevant between-group differences (p < 0.05). TCPs also demonstrated more CI than HCs (65% vs. 36%; p = 0.04). While global brain network analysis revealed no between-group differences, regional analysis indicated differences in node degree and betweenness centrality in several regions (p < 0.05), which was inconsistently associated with cognitive performance. In TCPs, CAG repeat length was positively correlated with delayed memory performance (r = 0.36; p = 0.02). A COMT group × genotype interaction effect was found for overall cognitive performance in TCPs, with risk carriers performing worse (p = 0.01). No effects were found for APOE, BDNF, or testosterone levels. In conclusion, our results support previous findings of a high incidence of CI in newly orchiectomized TCPs and provide novel insights into possible mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data from the current study are not publicly available but are available from the corresponding author by reasonable request.
Code availability
Not applicable.
References
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., & de Haes, J. C. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. https://doi.org/10.1093/jnci/85.5.365
Ahlbom, E., Prins, G. S., & Ceccatelli, S. (2001). Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Research, 892(2), 255–262. https://doi.org/10.1016/s0006-8993(00)03155-3
Ahles, T. A., & Hurria, A. (2018). New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions. Psychooncology, 27(1), 3–9. https://doi.org/10.1002/pon.4564
Ahles, T. A., & Root, J. C. (2018). Cognitive effects of cancer and cancer treatments. Annual Review of Clinical Psychology, 14, 425–451. https://doi.org/10.1146/annurev-clinpsy-050817-084903
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., … Kaufman, P. A. (2008). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment, 110(1), 143–152. https://doi.org/10.1007/s10549-007-9686-5.
Amidi, A., & Wu, L. M. (2019). Structural brain alterations following adult non-CNS cancers: A systematic review of the neuroimaging literature. Acta Oncologica, 58(5), 522–536. https://doi.org/10.1080/0284186X.2018.1563716
Amidi, A., Wu, L. M., Agerbaek, M., Larsen, P. L., Pedersen, A. D., Mehlsen, M., … Zachariae, R. (2015a). Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients. Psychooncology, 24(9), 1174–1180. https://doi.org/10.1002/pon.3804.
Amidi, A., Wu, L. M., Pedersen, A. D., Mehlsen, M., Pedersen, C. G., Rossen, P., … Zachariae, R. (2015b). Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Supportive Care in Cancer, 23(10), 2973–2979. https://doi.org/10.1007/s00520-015-2663-3.
Amidi, A., Agerbaek, M., Wu, L. M., Pedersen, A. D., Mehlsen, M., Clausen, C. R., … Zachariae, R. (2016). Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging and Behavior, 11(3):769–783. https://doi.org/10.1007/s11682-016-9552-3.
Amidi, A., Hosseini, S. M. H., Leemans, A., Kesler, S. R., Agerbæk, M., Wu, L. M., & Zachariae, R. (2017). Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. Journal of the National Cancer Institue, 109(12). https://doi.org/10.1093/jnci/djx085.
Bandak, M., Aksglaede, L., Juul, A., Rorth, M., & Daugaard, G. (2011). The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer. European Journal of Cancer, 47(17), 2585–2591. https://doi.org/10.1016/j.ejca.2011.05.026
Bandak, M., Jorgensen, N., Juul, A., Vogelius, I. R., Lauritsen, J., Kier, M. G., … Daugaard, G. (2016). Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis. Andrology, 4(3), 382–388. https://doi.org/10.1111/andr.12177.
Bandak, M., Jørgensen, N., Juul, A., Lauritsen, J., Kier, M. G. G., Mortensen, M. S., & Daugaard, G. (2018). Longitudinal changes in serum levels of testosterone and luteinizing hormone in testicular cancer patients after orchiectomy alone or bleomycin, etoposide, and cisplatin. European Urology Focus, 4(4), 591–598. https://doi.org/10.1016/j.euf.2016.11.018
Bassett, D. S., & Bullmore, E. (2006). Small-world brain networks. Neuroscientist, 12(6), 512–523. https://doi.org/10.1177/1073858406293182
Bell, M. J., Terhorst, L., & Bender, C. M. (2013). Psychometric analysis of the patient assessment of own functioning inventory in women with breast cancer. Journal of Nursing Measurement, 21(2), 320–334. https://doi.org/10.1891/1061-3749.21.2.320
Benedict, R., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins verbal learning test revised: Normative data and analysis of inter-form and test- retest reliability. Clinical Neuropsychology, 12(1), 43–55. https://doi.org/10.1076/clin.12.1.43.1726
Benton, A., & Hamsher, K. D. S. (1989). Multilingual aphasia examination. AJA Associates.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., … Yialamas, M. A. (2018). Testosterone Therapy in Men with Hypogonadism: An Endocrine Society. Journal of Clinical Endocrinology and Metabolism, 103(5), 1715–1744. https://doi.org/10.1210/jc.2018-00229.
Bianchi, V. E. (2018). The anti-inflammatory effects of testosterone. Journal of the Endocrine Society, 3(1), 91–107. https://doi.org/10.1210/js.2018-00186
Brown, C. M., Mulcahey, T. A., Filipek, N. C., & Wise, P. M. (2010). Production of proinflammatory cytokines and chemokines during neuroinflammation: Novel roles for estrogen receptors alpha and beta. Endocrinology, 151(10), 4916–4925. https://doi.org/10.1210/en.2010-0371
Bruno, J. L., Hosseini, S. M. H., Saggar, M., Quintin, E. M., Raman, M. M., & Reiss, A. L. (2017). Altered brain network segregation in fragile X syndrome revealed by structural connectomics. Cerebral Cortex, 27(3), 2249–2259. https://doi.org/10.1093/cercor/bhw055
Buskbjerg, C., Amidi, A., Demontis, D., Nissen, E. R., & Zachariae, R. (2019). Genetic risk factors for cancer-related cognitive impairment: A systematic review. Acta Oncologica, 58(5), 537–547. https://doi.org/10.1080/0284186X.2019.1578410
Buysse, D. J., Reynolds, C. F., 3rd., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213. https://doi.org/10.1016/0165-1781(89)90047-4
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26(7), 955–969. https://doi.org/10.1080/13803390490510905
Clinical trials registration. Retrieved from https://clinicaltrials.gov/ct2/show/NCT03452436.
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385–396. Retrieved August 25, 2020, from http://www.jstor.org/stable/2136404.
Deprez, S., Kesler, S. R., Saykin, A. J., Silverman, D., de Ruiter, M. B., & McDonald, B. C. (2018). International cognition and cancer task force recommendations for neuroimaging methods in the study of cognitive impairment in non-CNS cancer patients. Journal of the National Cancer Institute, 110(3), 223–231. https://doi.org/10.1093/jnci/djx285
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 98(12), 6917–6922. https://doi.org/10.1073/pnas.111134598
Ganz, P. A., Bower, J. E., Kwan, L., Castellon, S. A., Silverman, D. H. S., Geist, C., … Cole, S. W. (2013). Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behavior Immunity, 30, S99–S108. https://doi.org/10.1016/j.bbi.2012.07.015.
Hammond, J., Le, Q., Goodyer, C., Gelfand, M., Trifiro, M., & LeBlanc, A. (2001). Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. Journal of Neurochemistry, 77(5), 1319–1326. https://doi.org/10.1046/j.1471-4159.2001.00345.x
Handelsman, D. J., & Wartofsky, L. (2013). Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. The Journal of Clinocal Endocrinology and Metabolism, 98(10), 3971–3973. https://doi.org/10.1210/jc.2013-3375
Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer, 109(9), 1905–1913. https://doi.org/10.1002/cncr.22610
Hosseini, S. M. H. (2012). GAT: A graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS One, 7(7), e40709. https://doi.org/10.1371/journal.pone.0040709
Hosseini, S. M. H., Koovakkattu, D., & Kesler, S. R. (2012). Altered small-world properties of gray matter networks in breast cancer. BMC Neurology, 12(28), 28. https://doi.org/10.1186/1471-2377-12-28
Hosseini, S. M. H., Black, J. M., Soriano, T., Bugescu, N., Martinez, R., Raman, M. M., Kesler, S. R., & Hoeft, F. (2013). Topological properties of large-scale structural brain networks in children with familial risk for reading difficulties. NeuroImage, 71, 260–274. https://doi.org/10.1016/j.neuroimage.2013.01.013
Hosseini, S. M. H., Mazaika, P., Mauras, N., Buckingham, B., Weinzimer, S. A., Tsalikian, E., … Reiss, A. L. (2016). Altered integration of structural covariance networks in young children with type 1 diabetes. Human Brain Mapping, 37(11), 4034–4046. https://doi.org/10.1002/hbm.23293.
Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38(7), 926–934. https://doi.org/10.1016/j.ctrv.2012.05.002
IBM Corp. (2018). IBM SPSS Statistics for Windows, Version 26.0. IBM Corp.
Ingraham, L. J., & Aiken, C. B. (1996). An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology, 10(1), 120–124. https://doi.org/10.1037/0894-4105.10.1.120
Joly, F., Giffard, B., Rigal, O., De Ruiter, M. B., Small, B. J., Dubois, M., … Castel, H. (2015). Impact of cancer and its treatments on cognitive function: advances in research from the paris international cognition and cancer task force symposium and update since 2012. Journal Pain and Symptom Management, 50(6), 830–841. https://doi.org/10.1016/j.jpainsymman.2015.06.019
Kovacs, D., Vassos, E., Liu, X., Sun, X., Hu, J., Breen, G., … Li, T. (2009). The androgen receptor gene polyglycine repeat polymorphism is associated with memory performance in healthy Chinese individuals. Psychoneuroendocrinology, 34(6), 947-952. https://doi.org/10.1016/j.psyneuen.2009.01.007.
Lange, M., Giffard, B., Noal, S., Rigal, O., Kurtz, J. E., Heutte, N., … Joly, F. (2014). Baseline cognitive functions among elderly patients with localised breast cancer. European Journal of Cancer, 50(13), 2181–2189. https://doi.org/10.1016/j.ejca.2014.05.026.
Latora, V., & Marchiori, M. (2001). Efficient behavior of small-world networks. Physical Review Letters, 87(19), 198701. https://doi.org/10.1103/PhysRevLett.87.198701
Lee, D. M., Ulubaev, A., Tajar, A., Pye, S. R., Pendleton, N., Purandare, N., … Wu, F. C. (2010). Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: results from the European Male Ageing Study. European Journal of Endocrinology, 162(6), 1155–1164. https://doi.org/10.1530/eje-09-0970.
Li, M., & Caeyenberghs, K. (2018). Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review. Neuroscience and Biobehavioral Review, 92, 304–317. https://doi.org/10.1016/j.neubiorev.2018.05.019
Moffat, S. D., Zonderman, A. B., Metter, E. J., Blackman, M. R., Harman, S. M., & Resnick, S. M. (2002). Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. The Journal of Clinical Endocrinology & Metabolism, 87(11), 5001–5007. https://doi.org/10.1210/jc.2002-020419
Pedersen, A. D., Rossen, P., Mehlsen, M. Y., Pedersen, C. G., Zachariae, R., & von der Maase, H. (2009). Long-term cognitive function following chemotherapy in patients with testicular cancer. Journal of the International Neuropsychological Society, 15(2), 296–301. https://doi.org/10.1017/S1355617709090316
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009). Protective actions of sex steroid hormones in Alzheimer’s disease. Frontiers in Neuroendocrinology, 30(2), 239–258. https://doi.org/10.1016/j.yfrne.2009.04.015
Pullens, M. J., De Vries, J., & Roukema, J. A. (2010). Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psychooncology, 19(11), 1127–1138. https://doi.org/10.1002/pon.1673
Reitan, R. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271–276. https://doi.org/10.2466/pms.1958.8.3.271
Rubinov, M., & Sporns, O. (2010). Complex network measures of brain connectivity: Uses and interpretations. Neuroimage, 52(3), 1059–1069. https://doi.org/10.1016/j.neuroimage.2009.10.003
Santos, J. C., & Pyter, L. M. (2018). Neuroimmunology of behavioral comorbidities associated with cancer and cancer treatments. Frontiers in Immunology, 9, 1195. https://doi.org/10.3389/fimmu.2018.01195
Schagen, S. B., Boogerd, W., Muller, M. J., Huinink, W. T., Moonen, L., Meinhardt, W., & Van Dam, F. S. (2008). Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncologica, 47(1), 63–70. https://doi.org/10.1080/02841860701518058
Schilder, C. M., Seynaeve, C., Linn, S. C., Boogerd, W., Gundy, C. M., Beex, L. V., … Schagen, S. B. (2010). The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology, 19(4), 415–422. https://doi.org/10.1002/pon.1595.
Shaywitz, S. E., Shaywitz, B. A., Fulbright, R. K., Skudlarski, P., Mencl, W. E., Constable, R. T., Pugh, K. R., Holahan, J. M., Marchione, K. E., Fletcher, J. M., Lyon, G. R., & Gore, J. C. (2003). Neural systems for compensation and persistence: Young adult outcome of childhood reading disability. Biological Psychiatry, 54(1), 25–33. https://doi.org/10.1016/s0006-3223(02)01836-x
Skakkebæk, A., Bojesen, A., Kristensen, M. K., Cohen, A., Hougaard, D. M., Hertz, J. M., … Gravholt, C. H. (2014). Neuropsychology and brain morphology in Klinefelter syndrome - the impact of genetics. Andrology, 2(4), 632-640. https://doi.org/10.1111/j.2047-2927.2014.00229.x.
Skaali, T., Fossa, S. D., Andersson, S., Cvancarova, M., Langberg, C. W., Lehne, G., & Dahl, A. A. (2010). A prospective study of neuropsychological functioning in testicular cancer patients. Annals of Oncology, 22(5), 1062–1070. https://doi.org/10.1093/annonc/mdq553
Small, B. J., Rawson, K. S., Walsh, E., Jim, H. S., Hughes, T. F., Iser, L., … Jacobsen, P. B. (2011). Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer, 117(7), 1369–1376. https://doi.org/10.1002/cncr.25685.
Stouten-Kemperman, M. M., de Ruiter, M. B., Caan, M. W., Boogerd, W., Kerst, M. J., Reneman, L., & Schagen, S. B. (2015). Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping, 36(11), 4638–4647. https://doi.org/10.1002/hbm.22942
Stouten-Kemperman, M., de Ruiter, M., Boogerd, W., Kerst, J. M., Kirschbaum, C., Reneman, L., & Schagen, S. B. (2018). Brain Hyperconnectivity >10 years after cisplatin-based chemotherapy for testicular cancer. Brain Connectivity, 8(7), 398–406. https://doi.org/10.1089/brain.2017.0569
Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology, 22(11), 2233–2239. https://doi.org/10.1200/jco.2004.08.094
Thiel, A., Habedank, B., Herholz, K., Kessler, J., Winhuisen, L., Haupt, W. F., & Heiss, W. D. (2006). From the left to the right: How the brain compensates progressive loss of language function. Brain and Language, 98(1), 57–65. https://doi.org/10.1016/j.bandl.2006.01.007
Thilers, P. P., MacDonald, S. W. S., & Herlitz, A. (2006). The association between endogenous free testosterone and cognitive performance: A population-based study in 35 to 90 year-oldmen and women. Psychoneuroendocrinology, 31(5), 565–576. https://doi.org/10.1016/j.psyneuen.2005.12.005
van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M. E., & Rodenhuis, S. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90(3), 210–218. https://doi.org/10.1093/jnci/90.3.210
Wahjoepramono, E. J., Wijaya, L. K., Taddei, K., Martins, G., Howard, M., de Ruyck, K., … Martins, R. N. (2008). Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels. Journal of Alzheimer’s Disease, 15(1), 129–137. https://doi.org/10.3233/JAD-2008-15111.
Webster, K., Cella, D., & Yost, K. (2003). The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health and Quality Life Outcomes, 1, 79. https://doi.org/10.1186/1477-7525-1-79
Wechsler, D. (1997). Wechsler memory scale—Third edition manual. Psychological Corporation.
Wechsler, D. (2008). Wechsler adult intelligence scale—Fourth Editin (4th ed.). Psychological Corporation.
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116(14), 3348–3356. https://doi.org/10.1002/cncr.25098
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011a). International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet. Oncology, 12(7), 703–708. https://doi.org/10.1016/S1470-2045(10)70294-1
Wefel, J. S., Vidrine, D. J., Veramonti, T. L., Meyers, C. A., Marani, S. K., Hoekstra, H. J., … Gritz, E. R. (2011b). Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer, 117(1), 190–196. https://doi.org/10.1002/cncr.25298
Wefel, J. S., Vidrine, D. J., Marani, S. K., Swartz, R. J., Veramonti, T. L., Meyers, C. A., … Gritz, E. R. (2014). A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psychooncology, 23(6), 626–633. https://doi.org/10.1002/pon.3453.
Yaffe, K., Edwards, E. R., Lui, L. Y., Zmuda, J. M., Ferrell, R. E., & Cauley, J. A. (2003). Androgen receptor CAG repeat polymorphism is associated with cognitive function in older men. Biological Psychiatry, 54(9), 943–946. https://doi.org/10.1016/S0006-3223(03)00115-X
Zigmond, A. S., & Snaith, R. P. (1983). The Hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Acknowledgements
Claus H. Gravholt is a member of the European Reference Network on Rare Endocrine Conditions (ENDO-ERN), Project ID number 739543.
Funding
This work was supported by grants from Aase & Ejnar Danielsens Fond, Fabrikant Einar Willumsens Mindelegat, Fonden for Lægevidenskabens fremme, and C.C. Klestrup & hustru Henriette Klestrups Mindelegat.
Author information
Authors and Affiliations
Contributions
Author contributions included conception and study design (CB, RB, MA, CG, AA), data collection or acquisition (CB, MA, LH), statistical analysis (CB, HH, AA), interpretation of results (CB, RB, CG, HH, AA), drafting the manuscript work or revising it critically for important intellectual content (all authors) and approval of final version to be published and agreement to be accountable for the integrity and accuracy of all aspects of the work (all authors).
Corresponding author
Ethics declarations
The study was pre-registered at clinicaltrials.org (#NCT03452436) and approved by the regional scientific ethical committee (National Committee on Health Research Ethics trial registration No. 1-10-72-406-17). The data were collected and stored in accordance with the Danish Data Protection Agency guidelines.
Consent to participate
Written informed consent was obtained from all participants upon enrollment.
Conflicts of Interest
The authors declare no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Buskbjerg, C.R., Zachariae, R., Agerbæk, M. et al. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients. Brain Imaging and Behavior 16, 199–210 (2022). https://doi.org/10.1007/s11682-021-00492-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-021-00492-x